Menu
GeneBe

rs144384395

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_005379.4(MYO1A):c.2341A>G(p.Lys781Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,613,606 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 4 hom. )

Consequence

MYO1A
NM_005379.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.680
Variant links:
Genes affected
MYO1A (HGNC:7595): (myosin IA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional skeletal muscle myosin-1 (MYH1). Unconventional myosins contain the basic domains characteristic of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with autosomal dominant deafness. Alternatively spliced variants have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011663854).
BP6
Variant 12-57036315-T-C is Benign according to our data. Variant chr12-57036315-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 164583.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1}. Variant chr12-57036315-T-C is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd at 153 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO1ANM_005379.4 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 22/28 ENST00000300119.8
MYO1ANM_001256041.2 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 23/29
MYO1AXM_047428876.1 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 23/29
MYO1AXM_011538373.3 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 22/25

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO1AENST00000300119.8 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 22/281 NM_005379.4 P1
MYO1AENST00000442789.6 linkuse as main transcriptc.2341A>G p.Lys781Glu missense_variant 23/291 P1
MYO1AENST00000554234.5 linkuse as main transcriptc.1855A>G p.Lys619Glu missense_variant, NMD_transcript_variant 18/245

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
153
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00147
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000796
AC:
200
AN:
251146
Hom.:
0
AF XY:
0.000884
AC XY:
120
AN XY:
135716
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.00337
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00107
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.00141
AC:
2057
AN:
1461446
Hom.:
4
Cov.:
32
AF XY:
0.00134
AC XY:
976
AN XY:
727030
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.00132
Gnomad4 ASJ exome
AF:
0.00383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.00159
Gnomad4 OTH exome
AF:
0.00186
GnomAD4 genome
AF:
0.00101
AC:
153
AN:
152160
Hom.:
0
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.00183
Gnomad4 ASJ
AF:
0.00461
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.00147
Gnomad4 OTH
AF:
0.00191
Alfa
AF:
0.00127
Hom.:
0
Bravo
AF:
0.00110
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.000692
AC:
84
EpiCase
AF:
0.00153
EpiControl
AF:
0.00119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 18, 2021The c.2341A>G (p.K781E) alteration is located in exon 22 (coding exon 21) of the MYO1A gene. This alteration results from a A to G substitution at nucleotide position 2341, causing the lysine (K) at amino acid position 781 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 02, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 01, 2014Lys781Glu in exon 22 of MYO1A: This variant is not expected to have clinical sig nificance because it has been identified in 0.23% (20/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu ; dbSNP rs144384395). In addition, lysine (Lys) is not well conserved in mammals and across evolutionary distant species, and several computational prediction t ools suggest this variant may not impact the protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
Cadd
Benign
17
Dann
Benign
0.93
DEOGEN2
Benign
0.042
T;T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.10
N
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.012
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.2
M;M
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.43
N;N
REVEL
Benign
0.22
Sift
Benign
0.37
T;T
Sift4G
Benign
0.30
T;T
Polyphen
0.020
B;B
Vest4
0.30
MVP
0.68
MPC
0.12
ClinPred
0.013
T
GERP RS
2.2
Varity_R
0.071
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144384395; hg19: chr12-57430099; COSMIC: COSV99037929; COSMIC: COSV99037929; API